CCAP
$13.19
Crescent Capital BDC, Inc.
Recent News
Crescent Capital BDC (CCAP) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Crescent Capital BDC (CCAP), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Crescent Capital BDC (CCAP) Moves to Buy: Rationale Behind the Upgrade
Crescent Capital BDC (CCAP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Down 12% in 4 Weeks, Here's Why Crescent Capital BDC (CCAP) Looks Ripe for a Turnaround
Crescent Capital BDC (CCAP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Crescent Capital BDC Inc (CCAP) Q4 2025 Earnings Call Highlights: Strong Dividend Coverage Amid ...
Crescent Capital BDC Inc (CCAP) reports robust net investment income and a solid capital position, despite facing headwinds from unrealized losses and non-accrual increases.
Crescent Capital BDC Q4 Earnings Call Highlights
Crescent Capital BDC (NASDAQ:CCAP) reported fourth-quarter net investment income (NII) of $0.45 per share, down slightly from $0.46 in the prior quarter, as lower reference rates weighed on interest income. Management said results again exceeded the quarterly dividend, and the board declared a regul